Noticias de CLRB_US

Noticias del mercado

Últimas noticias sobre CLRB_US — 143 novedades recientes. Análisis, balances, opiniones y cobertura de prensa.

Ticker: CLRB_US ✕ 143 resultados
06/04/2026 CLRB_US — Xã Thanh Hà
Is Cellectar (CLRB) Stock in an Uptrend | Price at $2.71, Up 6.27% - Market Analysis
06/04/2026 CLRB_US — sonla.gov.vn
Is Cellectar (CLRB) Stock in an Uptrend | Price at $2.71, Up 6.27% - Weak Sell Rating
06/04/2026 CLRB_US — Xã Thanh Hà
Is Cellectar (CLRB) Stock Cheap at Current Price | Price at $2.68, Up 5.10% - Asset Allocation
06/04/2026 CLRB_US — Newser
Is Cellectar (CLRB) Stock in an Uptrend | Price at $2.71, Up 6.27% - Fed Rate Impact
06/04/2026 CLRB_US — sonla.gov.vn
Is Cellectar (CLRB) Stock Cheap at Current Price | Price at $2.68, Up 5.10% - Reversal Signals
06/04/2026 CLRB_US — laocai.gov.vn
Is Cellectar (CLRB) Stock in an Uptrend | Price at $2.71, Up 6.27% - Weak Sell Rating
06/04/2026 CLRB_US — laocai.gov.vn
Is Cellectar (CLRB) Stock Cheap at Current Price | Price at $2.68, Up 5.10% - Asset Allocation
10/03/2026 CLRB_US — GuruFocus
CLRB: Maxim Group Upgrades Cellectar Biosciences to Buy with $10 Target | CLRB Stock News
09/03/2026 CLRB_US — TipRanks
Cellectar Biosciences Charts Risky Path to Approvals
04/03/2026 CLRB_US — AlphaStreet
Earnings Summary: Cellectar Biosciences (CLRB) FY25 net loss narrows
04/03/2026 CLRB_US — Stock Titan
Cellectar (NASDAQ: CLRB) halves 2025 loss while pushing key cancer drugs
04/03/2026 CLRB_US — Investing.com
Earnings call transcript: Cellectar Biosciences Q4 2025 reveals strategic cost control
04/03/2026 CLRB_US — Yahoo Finance
Cellectar Biosciences, Inc. Q4 2025 Earnings Call Summary
04/03/2026 CLRB_US — Stock Titan
Cancer-drug firm gets FDA breakthrough tag, yet lost $21.8M in 2025
04/03/2026 CLRB_US — Investing News Network
Cellectar Biosciences Reports Financial Results for Year Ended 2025 and Provides Corporate Updates
04/03/2026 CLRB_US — TradingView
Cellectar Biosciences 2025 10-K — Net loss $8.35 EPS; no revenue reported
04/03/2026 CLRB_US — The Globe and Mail
Cellectar (CLRB) Q4 2025 Earnings Call Transcript
02/03/2026 CLRB_US — TradingView
Cellectar Biosciences Inc expected to post a loss of $2.02 a share - Earnings Preview
25/02/2026 CLRB_US — Yahoo Finance
Cellectar Biosciences to Report Full Year Financial Results and Host a Conference Call on Wednesday, March 4, 2026
17/02/2026 CLRB_US — Scott Coop
Cellectar Biosciences Expands Global Intellectual Property Estate

Página 7 de 8

keyboard_arrow_up